Kura Oncology, Inc. (KURA)
12.40
+0.51
(+4.29%)
USD |
NASDAQ |
Aug 24, 16:00
13.12
+0.72
(+5.81%)
After-Hours: 20:00
Kura Oncology Total Assets (Quarterly) : 587.79M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 587.79M |
| March 31, 2026 | 652.55M |
| December 31, 2025 | 738.36M |
| September 30, 2025 | 649.38M |
| June 30, 2025 | 682.42M |
| March 31, 2025 | 743.76M |
| December 31, 2024 | 1.041B |
| September 30, 2024 | 478.84M |
| June 30, 2024 | 515.12M |
| March 31, 2024 | 553.91M |
| December 31, 2023 | 448.94M |
| September 30, 2023 | 473.77M |
| June 30, 2023 | 494.74M |
| March 31, 2023 | 425.98M |
| December 31, 2022 | 456.31M |
| September 30, 2022 | 447.99M |
| June 30, 2022 | 471.42M |
| March 31, 2022 | 498.58M |
| December 31, 2021 | 534.05M |
| September 30, 2021 | 561.14M |
| June 30, 2021 | 584.89M |
| March 31, 2021 | 620.26M |
| December 31, 2020 | 647.21M |
| Date | Value |
|---|---|
| September 30, 2020 | 339.57M |
| June 30, 2020 | 353.00M |
| March 31, 2020 | 226.46M |
| December 31, 2019 | 241.97M |
| September 30, 2019 | 254.60M |
| June 30, 2019 | 265.68M |
| March 31, 2019 | 169.62M |
| December 31, 2018 | 182.38M |
| September 30, 2018 | 191.50M |
| June 30, 2018 | 129.63M |
| March 31, 2018 | 141.46M |
| December 31, 2017 | 95.85M |
| September 30, 2017 | 103.12M |
| June 30, 2017 | 55.85M |
| March 31, 2017 | 61.92M |
| December 31, 2016 | 69.82M |
| September 30, 2016 | 76.30M |
| June 30, 2016 | 81.74M |
| March 31, 2016 | 80.38M |
| December 31, 2015 | 87.26M |
| September 30, 2015 | 42.83M |
| June 30, 2015 | 47.53M |
| March 31, 2015 | 54.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 49.39M |
| Fortress Biotech, Inc. | 316.72M |
| Syndax Pharmaceuticals, Inc. | 703.65M |
| Spero Therapeutics, Inc. | 52.77M |
| Gossamer Bio, Inc. | 76.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 539.36M |
| Shareholders Equity (Quarterly) | 48.43M |
| Debt to Equity Ratio | 0.5049 |
| Current Ratio | 4.733 |
| Net Debt Paydown Yield | -0.10% |